Adrestia Therapeutics is an England-based biotechnology company that develops and markets synthetic rescue therapies to treat cancer and genetic disorders.
Business Model:
Revenue: $2.4M
Employees: 2-10
Address: Babraham Research Campus, Babraham
City: Cambridge
State: england
Zip: CB22 3AT
Country: GB
Adrestia Therapeutics is an England-based biotechnology company that develops and markets synthetic rescue therapies to treat cancer and genetic disorders.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2020 | Series A | - | 12/2020 | Series A | 2 | $232.6M |
GlaxoSmithKline Ahren Innovation Capital Ahren Innovation Capital GlaxoSmithKline |
9/2018 | Seed Round | 1 | - |
Ahren Innovation Capital Ahren Innovation Capital |
12/2020 | Series A | - |
GSK AHREN GSK AHREN |
9/2018 | Seed Round | 1 | - |
Ahren Innovation Capital Ahren Innovation Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|